Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel
- 15 July 1995
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology groupCancer, 1993
- Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.Journal of Clinical Oncology, 1993
- Survival After Phase II Treatment of Advanced Renal Cell Carcinoma with Taxol or High-Dose Interleukin-2Journal of Immunotherapy, 1993
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- A phase II trial of taxol in metastatic melanomaCancer, 1990
- Taxol: an antimitotic agent with a new mechanism of actionPharmacology & Therapeutics, 1984
- Central nervous system metastasis from breast carcinoma autopsy studyCancer, 1983
- Brain metastases in breast cancer patients receiving adjuvant chemotherapyCancer, 1982
- Adriamycin and 1-(2-Chlorethyl)-3-Cyclohexyl-1-Nitrosourea (CCNU) in the treatment of metastatic breast cancerCancer, 1978